• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI KASEI MEDICAL CO., LTD. ASAHI APS DIALYZERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI KASEI MEDICAL CO., LTD. ASAHI APS DIALYZERS Back to Search Results
Model Number APS-21SA
Device Problem Biocompatibility (2886)
Patient Problem Shock (2072)
Event Date 02/16/2016
Event Type  Injury  
Manufacturer Narrative
This incident occurred in (b)(6) and is reported to fda according to the requirement.Aps-21sa is identical model to rexeed-21s marketed in us.The product in complaint was not returned to the manufacturer and could not be analyzed.We reviewed manufacturing records, quality records of lot# weynyr.As a result, no abnormality was found in records.(b)(4) units of this lot#weynyr were manufactured, and no similar event using this lot# weynyr was reported globally.The symptoms observed in the events might be considered to be a dialyzer reaction*.Note: the dialyzer reaction is a broad group of events that include both anaphylactic and less well-defined adverse reactions of unknown cause."handbook of dialysis 4th ed." john t daugirdas et.Al., lippincott, williams & wilkins, 2006.Because of incompatibility of website and browser, we could not submit this mdr via web trader initially and sent paper mdr to fda by (b)(6).The paper mdr stamped with "(b)(6) 2016" (received date of fda), has been returned to us by post mail.
 
Event Description
(b)(6) 2016: the patient was given the online hdf treatment with dialyser (mfx-17meco).Just after the start of the treatment, he experienced shock symptom, then the dialysis was terminated, and he recovered.(b)(6) 2016: the treatment was changed back to that with the hemodialysis(hd) with the dialyser(aps-21sa).Soon after the start of the treatment, he has experienced anaphylactic reaction.He was given the treatment with some steroids(saxizon, predonin, celestamine) , and recovered.(b)(6) 2016: the patient was given the hd treatment with the other company's dialyser(fb210ub), and experienced an anaphylactic reaction soon after the start of the hd treatment. (b)(6) 2016: the treatment of the hemodialysis(hd) with the dialyser(aps-21sa, lot no 2exxxa) was started for the male patient hospitalized in japan.He was treated without any trouble.(b)(6) 2016: the treatment was changed to online hdf treatment with the other company's dialyser(mfx-17meco), and was completed without incident.(b)(6) 2016 the same treatment as on feb.4 was given to the patient without any trouble.(b)(6) 2016 the same treatment as above was given, and during the treatment he experienced a high fever of 40c.After the treatment, he has recovered to the normal temperature.(b)(6) 2016 the same treatment as above was given, and during the treatment he experienced a high fever of 40c again.He was hospitalized, was given the treatment, and recovered next day.His symptom was diagnosed as the suspicious bronchial infection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ASAHI APS DIALYZERS
Type of Device
DIALYZER
Manufacturer (Section D)
ASAHI KASEI MEDICAL CO., LTD.
1-105, kanda jimbocho,
chiyoda-ku,
tokyo, 101-8 101
JA  101-8101
Manufacturer (Section G)
ASAHI KASEI MEDICAL MT CORP. OITA WORKS
2111-2 oaza sato,
oita-shi,
oita, oita 870-0 396
JA   870-0396
Manufacturer Contact
kaoru furuya
1-105, kanda jinbocho,
chiyoda-ku,
tokyo, 101-8-101
JA   101-8101
332963735
MDR Report Key5610795
MDR Text Key43714370
Report Number8010002-2016-00010
Device Sequence Number1
Product Code KDI
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K051187
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 02/17/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/27/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/30/2018
Device Model NumberAPS-21SA
Device Lot NumberWEYNYR
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/17/2016
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/23/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
COAHIBITOR FOR INJECTION
Patient Outcome(s) Life Threatening;
Patient Age68 YR
Patient Weight48
-
-